
Neurodegenerative Diseases
Articles
-
Jan 24, 2025 |
link.springer.com | Binhai Campus |Neurodegenerative Diseases
AbstractPeripheral neuropathy (PN) identified as a significant contributor to disability in Spinocerebellar ataxia type 3 (SCA3) patients. This study seeks to assess the utility of current perception threshold (CPT) measurements in evaluating PN in individuals with SCA3 and aims to identify factors influencing CPT values in SCA3 and ascertain whether these values correlate with the severity of ataxia.
-
Jan 6, 2025 |
molecularneurodegeneration.biomedcentral.com | Neurodegenerative Diseases
It is unknown whether a cellular regulatory machinery might control seeding by tau, especially within the initial hours of cell entry. To identify factors that participate in tau seed amplification within 5 h of exposure, we used proximity labeling to identify VCP, which has previously been genetically and biochemically linked to chronic tau aggregation [17, 18, 19], and to inhibition of α-synuclein and TDP-43 seeding [20].
-
Nov 21, 2024 |
academic.oup.com | Rovira i Virgili |Neurodegenerative Diseases |San Antonio |Jose Luis
Substantial evidence supports the relationship between peripheral insulin resistance (IR) and the development of Alzheimer’s disease (AD)-dementia. However, the mechanisms explaining these associations are only partly understood. We aimed to identify a metabolic signature of IR associated with the progression from mild cognitive impairment (MCI) to AD-dementia. This is a case-control study on 400 MCI subjects, free of type 2 diabetes, within the ACE cohort, including individuals ATN+ and ATN-.
-
Oct 28, 2024 |
academic.oup.com | Neurodegenerative Diseases |Cheeloo College
Limb-girdle muscular dystrophy R7 is a rare genetic disease caused by homozygous or compound heterozygous variants in the titin-cap (TCAP) gene that results in the absence of the protein telethonin. The primary pathological features of limb-girdle muscular dystrophy R7 are fiber size variation, nuclear centralization, and abnormal mitochondrial distribution. The mechanisms underlying this disease are unclear, and there is currently no specific treatment for limb-girdle muscular dystrophy R7.
-
Sep 4, 2024 |
molecularneurodegeneration.biomedcentral.com | Shenzhen Shenzhen |Neurodegenerative Diseases
Experimental designThis translational study used preclinical (n = 224) and human (n = 59) TSPO-PET imaging data, which were consistently analyzed with ICCs for assessment of regional synchronicity of the tracer signal (Fig. 1A and B). Mice with microglia depletion via colony-stimulating factor 1 receptor (CSF1R) inhibition using PLX5622 were analyzed in contrast to age-matched placebo controls as a proof-of-concept experiment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →